Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
33710 Results Found
AHA Responds to Rep. Pitts' Graduate Medical Education Open Letter
AHA responds to Representative Joseph Pitts' Graduate Medical Education open letter.
AHA Comments to FDA Re: Draft Framework for Regulatory Oversight of Laboratory Developed Tests
AHA comments on the Food and Drug Administrations draft Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)
AHA, Others to Senate Finance Committee Re: No Additional Cuts to Hospitals to Pay for the SGR Fix.
AHA, health organizations letter to the Senate Finance Committee requesting no additional cuts to hospitals to pay for the SGR fix.
AHA Comments to VA Re: Expanded Access to Non-VA Care through the Veterans Choice Program
AHA comments on the Department of Veterans Affairs interim final rule on expanded access to non-VA care through the Veterans Choice Program.
AHA Comments on Proposed Rule: Summary of Benefits and Coverage and Uniform Glossary
AHA comments on the proposed revisions of the summary of benefits and coverage (SBC) published jointly by the departments of Labor, Health and Human Services, and Treasury.
AHA to Sen. Rob Portman Expressing Support for S. 688
AHA letter to Representative Rob Portman expressing support for S. 688, the Establishing Beneficiary Equity in the Hospital Readmission Program Act of 2015.
AHA to Rep. Renacci Expressing Support for H.R. 1343
AHA letter to Representative James Renacci expressing support for H.R. 1343, the Establishing Beneficiary Equity in the Hospital Readmission Program Act of 2015.
AHA Comments on FDA Draft Guidance on Mixing, Diluting, or Repackaging Biological Products
Docket No. FDA-2014-D-1525: Mixing, Diluting, or Repackaging Biological Products Outside the Scope of an Approved Biologics License Application; Draft Guidance for Industry
AHA Comments on FDA Draft Guidance on Repackaging of Certain Human Drug Products by Pharmacies
Docket No. FDA-2014-D-1524: Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities: Draft Guidance for Industry
AHA letter to House Energy and Commerce Committee opposing Section 2123
AHA letter to House Energy and Commerce Committee opposing Section 2123, Additional Payment for New Antimicrobial Drugs under Medicare, of the 21st Century Cures Act